Growth Metrics

Bio-Techne (TECH) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.24%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 30.54%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 71.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 71.10%
Dec 31, 2025 -278.72%
Sep 30, 2025 26.63%
Jun 30, 2025 26.45%
Mar 31, 2025 37.30%
Dec 31, 2024 47.70%
Sep 30, 2024 -44.95%
Jun 30, 2024 66.14%
Mar 31, 2024 -405.86%
Dec 31, 2023 -40.12%
Sep 30, 2023 -166.55%
Jun 30, 2023 23.14%
Mar 31, 2023 -143.60%
Dec 31, 2022 -26.06%
Sep 30, 2022 -9.28%
Jun 30, 2022 15.07%
Mar 31, 2022 -96.61%
Dec 31, 2021 -37.14%
Sep 30, 2021 70.87%
Jun 30, 2021 -99.80%
Mar 31, 2021 26.04%
Dec 31, 2020 -10.69%
Sep 30, 2020 13.11%
Jun 30, 2020 -30.61%
Mar 31, 2020 1,591.48%
Dec 31, 2019 41.92%
Sep 30, 2019 61.69%
Jun 30, 2019 -103.11%
Mar 31, 2019 30.30%
Dec 31, 2018 -41.57%
Sep 30, 2018 -50.12%
Jun 30, 2018 107.06%
Mar 31, 2018 -164.01%
Dec 31, 2017 53.49%
Sep 30, 2017 67.30%
Jun 30, 2017 -26.59%
Mar 31, 2017 27.02%
Dec 31, 2016 -64.06%
Sep 30, 2016 -36.65%
Jun 30, 2016 8.73%
Mar 31, 2016 -6.66%
Dec 31, 2015 18.88%
Sep 30, 2015 -143.21%
Jun 30, 2015 -29.64%
Mar 31, 2015 26.28%
Dec 31, 2014 -323.73%
Sep 30, 2014 -223.81%
Jun 30, 2014 51.86%
Mar 31, 2014 68.65%
Dec 31, 2013 -246.57%
Sep 30, 2013 -254.24%
Jun 30, 2013 39.06%
Mar 31, 2013 50.07%
Dec 31, 2012 -159.58%
Sep 30, 2012 -55.35%